Epithelioid mesothelioma is a rare form of cancer that affects the thin layer of tissue covering the majority of the body’s internal organs, known as the mesothelium. It is usually caused by exposure to asbestos and is a particularly aggressive form of cancer.
Epithelioid mesothelioma is rare, with an estimated 3,000 new cases in the United States each year. It can affect people of any age, but is most commonly seen in those aged between 50 and 70 years old. The condition is more common in men than women due to a higher exposure to asbestos in males.
Epithelioid mesothelioma is a difficult cancer to diagnose and treat. It is typically found in the chest cavity, although it can also spread to other areas of the body. The most common symptoms of the disease are chest pain, shortness of breath, and difficulty breathing.
The prognosis for epithelioid mesothelioma is poor. The cancer has a high rate of recurrence, meaning it can return even after treatment. It is also aggressive and spreads quickly, making it difficult to treat. The average life expectancy of those diagnosed with epithelioid mesothelioma is just 12 to 21 months.
Despite the grim outlook for epithelioid mesothelioma, there is still hope for those diagnosed with the condition. Treatment options such as surgery, chemotherapy, and radiation therapy are available and can help to increase life expectancy and improve quality of life. Clinical trials are also being conducted to explore potential new treatments for the disease.
The prognosis for epithelioid mesothelioma is poor, but with the right treatment, it is possible to extend life expectancy and improve quality of life. Those diagnosed with the condition should speak to their doctor about the best treatment options for them. It is also important to take steps to prevent exposure to asbestos, as this is the primary cause of the condition.